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INTRODUCTION
Upper gastrointestinal (GI) bleeding is blood loss
of gastrointestinal tract proximal to Treitz ligament. In
the Western country, the cause of upper GI bleeding
is peptic ulcer (50%), while in Indonesia it was
leakage of esophageal varices (70-75%). Incidence
of upper GI bleeding is 4 times higher than lower GI
bleeding.1,2 Clinical manifestation of upper GI
bleeding varied from occult bleeding to a life
threatening condition. Obvious clinical manifestations
are hematemesis and melena. The occult bleeding in
gastrointestinal has prevalence of 1 from 20 adults.1,3
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ABSTRACT
Background: Immunological fecal occult blood test (FOBT) using anti human hemoglobin (Hb) has
a low sensitivity in detecting upper gastrointestinal (GI) bleeding, due to Hb degradation. Transferrin
(Tf) is more stable in stool when compared to Hb, provides an alternatives on diagnosing upper GI
bleeding. This study aim to determine the advantage of FOBT Hb + Tf in detecting upper GI bleeding
compared with FOBT Hb alone.
Method: This study was conducted by comparing the diagnostic value of rapid immunochromatographic
FOBT that use anti-human Hb alone, with the one using combination of anti human Hb &
Tf simultaneously in detecting upper GI bleeding. Stool sample from 48 patients with upper GI bleeding
and 29 controls (without any upper GI bleeding) were collected then tested with both FOBT methods.
Endoscopy study was used as gold standard endoscopy to determine test’s diagnostic value.
Results: In detecting upper GI bleeding, the sensitivity of FOBT Hb + Tf (85.42%) was higher than
FOBT Hb (29.17%). The specifity of both methods were accurate at 89.66% and 93.10% respectively.
Positive predictive values (PPV) for both methods were also good at 93.18% and 87.50% while negative
predictive value (NPV) FOBT Hb + Tf (78.79%) were higher than FOBT Hb (44.26%).
Conclusion: Between these two test methods on detecting upper GI bleeding, FOBT Hb + Tf has
higher sensitivity, PPV and NPV value compared to FOBT Hb. It is advisable to use FOBT Hb + Tf for
upper GI bleeding screening.
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Endoscopy was the gold standard for diagnostic test
in upper GI bleeding. However, endoscopy is
a semi-invasive test and gives uncomfortable feeling
for patients. Hence, screening tests that are non-
invasive, simple, and easy to applicate is needed to
detect upper GI bleeding. One of them is by
performing fecal occult blood test (FOBT).2
FOBT were used in patients with high suspicion of
gastrointestinal bleeding. The FOBT has several
variations in methods and diagnostic value.2,4,5,6
Conventional FOBT uses a chemical methods based
on peroxidase enzyme activity. This method has
the weakness that is showing a false positive result on
a diet of food containing hematin. Several chemicals
can also influence its reactions and causing false
negative results. In order to overcome those
disadvantages, an immunology method was developed
by use of hemoglobin antibody (Hb). This method has
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no dietary limitation and gives high diagnostic
accuracy. But, in spite of it all, the variation of stool
hydration, degradation of existing Hb by protease,
absorption of mucin, loss of Hb antigenicity due to
Enterobacter activity, have made no specific and
sensitive FOBT methods in screening and detecting
upper GI bleeding.4,6,7
The development of FOBT examination conducted
by using anti-human Hb and anti-transferrin (Tf) to
detect fecal Hb and Tf simultaneously.4,7,8,9,10
Detection of fecal Tf is an alternative method for
screening of upper GI bleeding, because Tf is more
stable in stool compared with Hb. Recently, FOBT
Hb + Tf were commonly performed to screen upper
GI bleeding in colon cancer or colon polyps. Miyoshi
et al, suggested that FOBT Hb + Tf to high sensitivity
in lower GI bleeding (sensitivity 90%).9,10 Typical
studies to detect upper GI bleeding is very limited.4, 5
Chiang et al, suggested that FOBT Hb + Tf would
increase FOBT diagnostic value when compared to
conventional methods.4 The diagnostic value of FOBT
Hb + Tf in upper GI bleeding detection were never
conducted or reported in Indonesia.
Based on this, the study will be conducted
diagnostic value of FOBT Hb + Tf compared with
FOBT Hb alone. This is important to the selection of
kits to be used in laboratory, because it has wide
variation of diagnostic value in each method. We need
to understand whether the diagnostic value
[sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV)] of FOBT Hb + Tf
are better than FOBT Hb alone in detecting upper GI
bleeding. The objectives of this study is to determine
advantages of FOBT Hb + Tf in detecting upper GI
bleeding compared with FOBT Hb alone. From this
study, we hope to be able to decide a screening
test that is non-invasive, simple, easy to do with good
diagnostic value, thus increasing the health service in
general.
METHOD
The study used analytical observational cross
sectional design. The study population was all
dyspeptic patients who underwent endoscopy
procedure at the Division of Gastroenterology,
Department of Internal Medicine, Saiful Anwar hos-
pital.
The minimum sample size were 55 patients.
consent); (2) the presence of ulcer, erosion, or etc
that could lead to upper GI bleeding from endoscopic
examination. Inclusion criteria for control samples
are: (1) patient willing to undertake the study
(approved informed consent); (2) normal result in
endoscopic examination or normal upper GI; (3)
endoscopic result showed only upper GI edema
without erosion, ulcer, polyps, or malignancy. Samples
exclusion criteria are: (1) patient are not willing to
undertake the study; (2) there was melena,
hematochezia, or hemorrhoid bleeding; (3) female
patients who were menstrual period
Materials of study were stools taken from patients
samples before undergoing endoscopic. Samples
then tested for FOBT Hb + Tf (Oncoprobe®),
and FOBT Hb alone (delta) in accordance to the
kit procedure. Cut off value to detect Hb on FOBT
Hb + Tf are 200 ng/mL or 10 mg Hb/g stool,
and 40 ng/mL transferrin. Positive results were
defined if one or two red stripes are shown on T line
or one red strip on the C line. If the strip is present on
Hb line, it proved Hb content in the stool.
The same condition were applied to Tf. If there
was pink strip on the Tf line, it suggested the
presence of Tf in the stool. If there were two pink
strips, each on Hb and Tf line, it suggested the
presence of Hb and Tf in stool simultaneously.
On the contrary, results will be defined as negative
if there were only one pink strip appeared in control
line. Presence or absence of upper GI bleeding
was approved by the Gastroenterologist in
Saiful Anwar General Hospital. The sensitivity,
specificity, PPV, and NPV were counted using
McNemar formula.
RESULTS
There were 77 samples that comprises to 48 cases
and 29 control population. Male patients were
36 individuals (46.75%) with age ranges from 28 – 80
years old with 48.06 ± 15.61 (mean ± SD) years old.
Female patients were 41 individual (53.25%), with age
ranges from 18 – 74 years old with  47.37 ± 13.64
(mean ± SD) years old. From 48 cases population,
they were comprised of various clinical condition as
seen in table 1 with test result listed in table 2 and
compared as negative and positive result in table 3.
From 29 control samples, they were comprised of
clinical conditions as seen in table 4, with test result
listed in table 5 and compared as negative and positive
result in table 6. Diagnostic value of FOBT Hb + Tf
and FOBT Hb alone were depicted in table 7.
However, to obtain control sample is a lot more
difficult than endoscopic cases, therefore we use 2 : 1
ratio between case and control, after the statistical
calculation were obtained at least 42 the number of
cases and 21 controls.
Case samples inclusion criteria are: (1) patient
willing to undertake the study (approved informed
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Table 1. The result of FOBT test from upper GI bleeding cases  
Case group n (%) 
FOBT result* 
Hb + Tf Hb  
Positive Negative Positive Negative 
Erosive upper GI 17 (35.42) 16 1 - 17 
Erosive upper GI + ulcer 10 (20.83) 8 2 8 2 
Erosive upper GI + polyp 2 (4.17) 1 1 - 2 
Erythematous upper GI + mild erosive  11 (22.92) 10 1 1 10 
Erythematous upper GI + polyp 1 (2.08) - 1 - 1 
Upper GI ulcer 7 (14.58) 6 1 5 2 
Total 48 (100) 41 7 14 34 
* FOBT Hb + Tf defined as positive if Tf positive 
 
Table 2. The FOBT result from the case group 
Case group FOBT Hb + Tf positive* FOBT Hb positive Tf Hb Tf + Hb 
Erosive upper GI 16 7 6 - 
Erosive upper GI + ulcer 8 10 8 8 
Erosive upper GI + polyp 1 2 1 - 
Erythematous upper GI + mild erosive  10 10 9 1 
Erythematous upper GI + polyp - - - - 
Upper GI ulcer 6 7 6 5 
Total 41 36 30 14 
* FOBT Hb + Tf defined as positive if Tf must be positive 
Table 3. The comparison of FOBT Hb + Tf with FOBT Hb on the case group 
Case group n (%) 
FOBT results* 
Hb + Tf Hb 
Positive Negative Positive Negative 
Erosive upper GI 17 (35.42) 17 - - 17 
Erosive upper GI + ulcer 10 (20.83) 10 - 8 2 
Erosive upper GI + polyp 2 (4.17) 2 - - 2 
Erythematous upper GI + mild erosive  11 (22.92) 11 - 1 10 
Erythematous upper GI + polyp 1 (2.08) - 1 - 1 
Upper GI ulcer 7 (14.58) 7 - 5 2 
Total 48 (100) 47 1 14 34 
* FOBT Hb + Tf defined as positive if both Tf/Hb/ are positive 
 
Table 4. The FOBT result on the control group  
Control group n (%) 
FOBT Results* 
Hb + Tf Hb 
Positive Negative Positive Negative 
Erythematous gastritis 19 (65.51) 2 17 1 18 
Normal 4 (13.79) - 4 - 4 
Gastropathy 2 (6.90) - 2 - 2 
Esophagitis 1 (3.45) - 1 - 1 
Pyloric lumen narrowing with unclear cause 1 (3.45) - 1 1 - 
Erythematous upper GI & bile reflux 2 (6.90) 1 1 - 2 
Total 29 (100) 3 26 2 27 
* FOBT Hb + Tf positive if Tf must be positive 
 
Table 5. Comparison of FOBT Hb + Tf with FOBT Hb on control group 
Control group n (%) 
FOBT Results* 
Hb + Tf Hb  
Positive Negative Positive Negative 
Erythematous gastritis 19 (65.51) 2 17 1 18 
Normal 4 (13.79) - 4 - 4 
Gastropathy 2 (6.90) - 2 - 2 
Esophagitis 1 (3.45) - 1 - 1 
Pyloric lumen narrowing with unclear cause 1 (3.45) 1 - 1 - 
Erythematous upper GI & bile reflux 2 (6.90) 1 1 - 2 
Total 29 (100) 4 25 2 27 



























The result showed that FOBT Hb + Tf has better 
sensitivity, PPV, and NPV compared to FOBT Hb 
only, while specificity of FOBT Hb is better than FOBT 
Hb + Tf (table 7). This is appropriate with study 
conducted by Chiang et al, when they were 
comparing FOBT Hb + Tf with FOBT chemical 
method (o-toluidine) and immunochemical methods 
(OC-Hemodia test) on detecting upper GI bleeding. 
From their study, Chiang et al had proven that FOBT 
Hb + Tf has better diagnostic value.4 
In this study, we evaluated FOBT Hb + Tf positive  
in two ways, which is defined as positive if Tf is  
positive because we did not perform colonoscopy  
to patients, therefore by using only exc lusion criteria,  
there were still a possibility of occult bleeding in  
lower GI. However from the procedures in our kit, it  
would be defined as positive if one or both Tf and Hb  
were proven positive by the second method. Results  
shows that sensitivity of FOBT Hb + Tf were increased  
if appropriate guidance kit, which was mentioned  
positive when Tf or Hb or both strips appear.  
Nevertheless, the specificity of the test were 
decreased.11-13 
Diagnostic value of FOBT is varies widely,  
depending on the principle of the method , plants, and  
other conditions such hydration and stool sample.  
Bleeding of upper GI tract release haptoglobin,  
fibrinogen, and transferrin. Transferrin is a glyco- 
protein resistant to bacterial degradation, therefore its  
condition in stool is a lot more stable than Hb. FOBT  
that verify only Hb in stools has false negative due to  
stool hydration condition, Hb degradation by protease  
enzymes, vanished antigenicity of Hb resulted from  
Enterobacter and mucin absorption. FOBT Hb-only  
was better used to detect lower GI bleeding e.g.  
carcinoma and colonic polyps, while simultaneous 
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Hb + Tf FOBT was better than Hb only or chemical 
tests to detect upper GI bleeding.4,7-10,14-17  
 In this study, FOBT Hb + Tf on control population  
showed 25 out of 29 control samples were negative  
both in Tf and Hb. While in FOBT Hb only, we found  
27 negative sa mples out of 29 control population.  
In FOBT Hb + Tf, 2 controls were positive for both Tf  
and Hb in patients with erythematous gastritis.  
This was possible due to intermitten occult bleeding in  
stomach, therefore at time of endoscopy evaluation,  
we did not find any abnormalities which is one of them  
was positive in FOBT Hb only. We also found one  
patient with pylori lumen narrowing (control) whom in  
FOBT Hb + Tf test were positive Hb only, in which,  
the result of FOBT Hb only (delta) was also positive.  
Whether this because the Tf level is too low to detect  
or because other cause, could not be ascertained from  
this study. 
In this study, 48 patients with upper GI bleeding  
that were examined by FOBT + Tf, there were 6  
patients with negative Tf but positive Hb, in which 3  
of them is also positive in FOBT Hb-only. The positive  
Hb and negative Tf result emerged due to Tf level in  
these patients is too low, thus made it undetectable in  
FOBT Hb +Tf. However, we can not validate it  
because we did not measure Tf level in the patient’s  
blood. From 48 patients with upper GI bleeding, in  
FOBT Hb + Tf, we found 22 samples positive in Hb,  
but in FOBT Hb only the result were negative.  
 This was somewhat surprising, because the cut off  
point of FOBT Hb only is just 50 ng/mL, while in FOBT  
Hb + Tf the cut-off point 200 ng/mL. Therefore, it is  
supposed to be positive in FOBT Hb only if it is  
positive in FOBT Hb + Tf, but the truth was not like  
that. Whether this results from different use of  
anti-human Hb in each tests therefore provide  
different sensitivity, also could not be ascertained 
5  
 
Table 6. The result of FOBT in control group 
Cases group FOBT Hb + Tf positive* FOBT Hb positive Tf Hb Tf + Hb 
Erythematous gastritis 2 2 2 1 
Normal - - - - 
Gastropathy - - - - 
Esophagitis - - - - 
Pyloric lumen narrowing with unclear cause - 1 - 1 
Erythematous upper GI and bile reflux 1 - - - 
Total 3 3 2 2 
*FOBT Hb + Tf positive, Tf must be positive 
Table 7. The diagnostic on 2 types of FOBT  
 FOBT Hb + Tf FOBT Hb 
 Tf positive Both of Tf/Hb positive 
Sensitivity (%) 85.42 97.92 29.17 
Specificity (%) 89.66 86.21 93.10 
Positive predictive value (%) 93.18 92.16 87.50 
Negative predictive value (%) 78.79 96.15 44.26 
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CONCLUSION
The results of this study indicate that diagnostic
value of FOBT Hb + Tf was better than FOBT Hb
only in detecting upper GI bleeding. Therefore, FOBT
Hb + Tf can be used for upper GI bleeding screening
tests.
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